Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 59151 - 59175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Piroxicam	Approved Investigational	CCNA2	890	downregulated	Piroxicam results in decreased expression of CCNA2 mRNA	4q27	A23661
Piroxicam	Approved Investigational	CCNB2	9133	downregulated	Piroxicam results in decreased expression of CCNB2 mRNA	15q22.2	A23661
Piroxicam	Approved Investigational	CCNC	892	downregulated	Piroxicam results in decreased expression of CCNC mRNA	6q16.2	A23661
Piroxicam	Approved Investigational	CCND1	595	upregulated	Piroxicam results in increased expression of CCND1 mRNA	11q13.3	A23661
Piroxicam	Approved Investigational	CCND3	896	downregulated	Piroxicam results in decreased expression of CCND3 mRNA	6p21.1	A23661
Piroxicam	Approved Investigational	CD44	960	upregulated	Piroxicam results in increased expression of CD44 mRNA	11p13	A23661
Piroxicam	Approved Investigational	CD55	1604	upregulated	Piroxicam results in increased expression of CD55 mRNA	1q32.2	A23661
Piroxicam	Approved Investigational	CDC25A	993	downregulated	Piroxicam results in decreased expression of CDC25A mRNA	3p21.31	A23661
Piroxicam	Approved Investigational	CDC6	990	upregulated	Piroxicam results in increased expression of CDC6 mRNA	17q21.2	A23661
Piroxicam	Approved Investigational	CDCA3	83461	downregulated	Piroxicam results in decreased expression of CDCA3 mRNA	12p13.31	A23661
Piroxicam	Approved Investigational	CDCA4	55038	upregulated	Piroxicam results in increased expression of CDCA4 mRNA	14q32.33	A23661
Piroxicam	Approved Investigational	CDCA8	55143	downregulated	Piroxicam results in decreased expression of CDCA8 mRNA	1p34.3	A23661
Piroxicam	Approved Investigational	CDK1	983	downregulated	Piroxicam results in decreased expression of CDK1 mRNA	10q21.2	A23661
Piroxicam	Approved Investigational	CDK2	1017	downregulated	Piroxicam results in decreased expression of CDK2 mRNA	12q13.2	A23661
Piroxicam	Approved Investigational	CEBPB	1051	downregulated	Piroxicam results in decreased expression of CEBPB mRNA	20q13.13	A23661
Piroxicam	Approved Investigational	CEBPG	1054	upregulated	Piroxicam results in increased expression of CEBPG mRNA	19q13.11	A23661
Piroxicam	Approved Investigational	CENPE	1062	downregulated	Piroxicam results in decreased expression of CENPE mRNA	4q24	A23661
Piroxicam	Approved Investigational	CEP170	9859	upregulated	Piroxicam results in increased expression of CEP170 mRNA	1q43	A23661
Piroxicam	Approved Investigational	CEP55	55165	downregulated	Piroxicam results in decreased expression of CEP55 mRNA	10q23.33	A23661
Piroxicam	Approved Investigational	CHMP4A	29082	upregulated	Piroxicam results in increased expression of CHMP4A mRNA	14q12	A23661
Piroxicam	Approved Investigational	CIZ1	25792	upregulated	Piroxicam results in increased expression of CIZ1 mRNA	9q34.11	A23661
Piroxicam	Approved Investigational	CKS2	1164	downregulated	Piroxicam results in decreased expression of CKS2 mRNA	9q22.2	A23661
Piroxicam	Approved Investigational	CLCN3	1182	downregulated	Piroxicam results in decreased expression of CLCN3 mRNA	4q33	A23661
Piroxicam	Approved Investigational	CLEC2B	9976	upregulated	Piroxicam results in increased expression of CLEC2B mRNA	12p13.31	A23661
Piroxicam	Approved Investigational	CLGN	1047	downregulated	Piroxicam results in decreased expression of CLGN mRNA	4q31.1	A21015

Displaying entries 59151 - 59175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability